RxDoctor Payments Data

Jerry Kunz, MD

Family Medicine · Chillicothe, OHNPI 1871596668

Payments from drug & device makers

$12,578in general payments, 2019–2025

Across 893 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Pfizer$814
  • Amgen$653
  • plus $5K from 33 others

What the payments were for

  • Food & beverage$12,33298%
  • Education$2462%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,578 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$98,034
Medicare patients
228
Services billed
1,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban102$96,819
OzempicSemaglutide67$86,894
JardianceEmpagliflozin74$77,708
MounjaroTirzepatide62$74,895
TrulicityDulaglutide37$43,371
XareltoRivaroxaban33$37,873
FarxigaDapagliflozin Propanediol42$34,815
RybelsusSemaglutide19$19,654
ShingrixVaricella-Zoster Ge/As01b/Pf86$18,981
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$18,306
Janumet XrSitagliptin Phos/Metformin Hcl16$16,333
Spiriva RespimatTiotropium Bromide17$12,705
KerendiaFinerenone13$11,743
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$11,691
JanuviaSitagliptin Phosphate15$9,980

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,555$118,26699 claims
Novo NordiskOzempic, Rybelsus$1,389$106,54986 claims
PfizerEliquis$814$96,819102 claims
Boehringer IngelheimJardiance, Spiriva Respimat$412$90,41391 claims
AstraZenecaFarxiga, Symbicort$1,377$38,21755 claims
Johnson & JohnsonXarelto$377$37,87333 claims
GSKShingrix, Trelegy Ellipta$116$37,286102 claims
MerckJanumet Xr, Januvia$592$26,31331 claims
BayerKerendia$588$11,74313 claims
Astellas Pharma US IncMyrbetriq$556$5,47012 claims
AbbVieSynthroid$1,691$1,36639 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →